Vulvar squamous cell carcinoma (VSCC), a rare gynecologic malignancy, has been rising in incidence. Molecular classification on the basis of human papilloma virus (HPV) and tumor protein 53 (p53) ...

A retrospective study reports that the incidence of vulval SCC has remained stable over the past decade, but the diagnosis is delayed due to poor awareness and clinical presentation challenges.

Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first ...